Stopping Mounjaro: Weight Regain and Lost Health Benefits Revealed in Study

Описание: Mounjaro weight loss drug tirzepatide obesity regain weight health benefits blood pressure cholesterol glucose study
Discover what happens when people stop taking Mounjaro, the popular weight-loss jab containing tirzepatide. This video explores a new study from the Surmount-4 trial, showing that not only do users regain much of their lost weight, but they also lose key health improvements like lower blood pressure, reduced bad cholesterol, and better blood sugar control.
We'll break down the research findings, including how 82% of participants regained 25% or more of their weight just one year after stopping. Experts weigh in on why this happens and the importance of long-term weight management for sustaining cardiometabolic benefits.
Learn about related studies on heart health risks and pregnancy outcomes for women using these drugs. Whether you're considering Mounjaro or other weight-loss medications like semaglutide, this video helps you understand the science behind maintaining results.
Keywords: Mounjaro, tirzepatide, weight loss drugs, obesity treatment, regain weight, cardiometabolic health, clinical trial, Surmount-4, Eli Lilly
Stay tuned for more on health and wellness topics!